A randomized controlled study of Shenfuhuang Compound in the treatment of sepsis
- Conditions
- sepsis
- Registration Number
- ChiCTR2400088940
- Lead Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) consistent with the diagnosis of sepsis;<br>(2) age =18 years old;<br>(3) Voluntarily participated in this study and signed informed consent.
(1) pregnant or preparing for pregnancy;<br>(2) patients with severe mental disorders;<br>(3) the expected survival time of patients is less than 28 days due to underlying diseases, such as poor control of malignant tumors, cardiac arrest within the past 30 days, etc.;<br>(4) survival status of plants;<br>(5) confirmed or highly suspected acute infectious diseases, such as active viral hepatitis, active tuberculosis, etc.;<br>(6) allergy to the active ingredients of the test drug or its excipients;<br>(7) participated in clinical intervention trials within the past 3 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 28-day mortality;
- Secondary Outcome Measures
Name Time Method SOFA score;Length of ICU stay;DIC score;